Drawing for VIVALIS

USPTO serial 79099607

VIVALIS

Reviewed by CopyMark Law Group

Reg. 4243981Status 404
Filing date
Status date
Registration date
Nov 20, 2012
Examiner
RICHARDS, LESLIE
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVALIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Molecules obtained from biotechnologies, proteins, and biotechnological products for research and diagnosis; proteins in raw material form for scientific and medical research; micro-organisms, namely, cultures of microorganisms other than for medical and veterinary use; cells, avian embryonic stem cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for research and diagnosis, all these products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary useSECTION 18 - CANCELLED—
005Prophylactic and therapeutic medicines, pharmaceutical and veterinary products, namely, medical, biological, biotechnological and/or genetic technology preparations and products for medical, pharmaceutical or veterinary use for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; micro-organisms, cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for therapy and diagnosis, all for medical use; molecules and antibodies for medical or pharmaceutical use; biotechnological products for medical or pharmaceutical use, namely, for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; diagnosis products for medical or pharmaceutical use, namely, prophylactic and therapeutic vaccines, * none relating to sexual health *SECTION 18 - CANCELLED—
042Scientific services, namely, scientific research; research and development of new products or process for production and/or purification of biological products for third parties, biological research and research in the fields of bacteriology, virology, immunology, biotechnology, genetics, medicine, pharmacology, and scientific research services for medical purposes; scientific research services for pharmaceutical purposes and scientific research services for veterinary purposes; development of technologies and scientific and industrial research to obtain and prepare cells, cell lines, and to produce and/or purify proteins, viruses, human and animal materialSECTION 18 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 11, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 23, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 24, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 2, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 2, 2015INPCINVALIDATION PROCESSED—
Apr 25, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 25, 2014C18.CANCELLED SECTION 18-TOTAL—
Aug 25, 2014CANTCANCELLATION TERMINATED NO. 999999—
Aug 15, 2014CANGCANCELLATION GRANTED NO. 999999—
May 22, 2014INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 28, 2014PETCCANCELLATION INSTITUTED NO. 999999—
Aug 18, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 25, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 6, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 6, 2013FIMPFINAL DISPOSITION PROCESSED—
Mar 6, 2013LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 2, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 20, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 4, 2013LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 18, 2012COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Dec 18, 2012PLGLASSIGNED TO PARALEGAL—
Dec 18, 2012LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Dec 1, 2012GPNXNOTIFICATION PROCESSED BY IB—
Nov 20, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2012LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 12, 2012ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 14, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 27, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 8, 2012ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 29, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 16, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 9, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 23, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 21, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2012ALIEASSIGNED TO LIE—
Feb 22, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 18, 2011RFNTREFUSAL PROCESSED BY IB—
Aug 31, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 31, 2011RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2011DOCKASSIGNED TO EXAMINER—
Aug 2, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 27, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance